Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 1999Journal of Antimicrobial ChemotherapyOpen Access

Comparative in-vitro activity of voriconazole (UK-109,496) and six other antifungal agents against clinical isolates of Scedosporium prolificans and Scedosporium apiospermum

View Full Paper
Ask AI
Bookmark
Share

Authors

MCManuel Cuenca‐EstrellaInstituto de Salud Carlos IIIBRBeatriz Ruiz-Dı́ezConsejo Superior de Investigaciones CientíficasJMJoaquı́n V. Martı́nez-SuárezInstituto Nacional de Investigación y Tecnología Agraria y Alimentaria

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Cuenca‐Estrella et al. (1999) studied this question.

synapsesocial.com/papers/6a7cec629092f18ef00eb322https://doi.org/10.1093/jac/43.1.149
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1In vitro studies of activity of voriconazole (UK-109,496), a new triazole antifungal agent, against emerging and less-common mold pathogens1997 · 190 citations
  2. 2National Committee for Clinical Laboratory Standards1980 · 14,792 citations
  3. 3Ecology and physiology of the emerging opportunistic fungi <i>Pseudallescheria boydii</i> and <i>Scedosporium prolificans</i>1994 · 112 citations
  4. 4Deep Infections Caused by Scedosporium prolificans: A Report on 16 Cases in Spain and a Review of the Literature1997 · 213 citations
  5. 5Improved medium for fluconazole susceptibility testing of Candida albicans1994 · 69 citations